x

Cerca un progetto di ricerca

* (*) campo obbligatorio

112 Risultato/i

Ordinato per

Finanziato da un ente associato a IRDiRC = Membro di una ERN =

Progetti di ricerca

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

GERMANIA

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

AUSTRIA

WIEN
WIEN

Dissecting the Role of HDAC1 in T Cell Lymphoma
Medizinische Universität Wien
Klinisches Institut für Pathologie

AUSTRIA

WIEN
WIEN

Find tumor immune evasion strategies by cellular barcoding
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

CDK8 - a weapon to arm NK cells against leukemia
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

FINLANDIA

Finland
KUOPIO

FINLANDIA

Finland
TAMPERE

Finanziato da un ente associato a IRDiRCGenomics based tools for personalized treatment in pediatric cancer (GEPARD)
TAYS - Tampere University Hospital
Lasten hematologian ja onkologian osasto

FINLANDIA

Finland
TAMPERE

Finanziato da un ente associato a IRDiRCNovel targeted therapies for acute leukemias
Tampere University
Tampere Center for Child Health Research

FRANCIA

ILE-DE-FRANCE
PARIS

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANIA

Bayern
ERLANGEN

Late Effects Surveillance System (LESS) for oncological diseases in children und adolescents
Kinder- und Jugendklinik des Universitätsklinikums Erlangen
Kinder- und Jugendklinik

GERMANIA

Berlin
ADDRESS: NOT PROVIDED - DE

Finanziato da un ente associato a IRDiRCTurbiCAR: UniCAR-based therapy of CD123-positive leukemias
Institution: Information not provided - DE

GERMANIA

Berlin
BERLIN

ALL-REZ BFM: Observational study biobank for children with Acute Lymphoblastic Leukemia
Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie

GERMANIA

Berlin
BERLIN

Finanziato da un ente associato a IRDiRCIRMA-4-ALL: Measurement of individual therapy response of acute lymphoblastic leukemias
Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie

GERMANIA

Niedersachsen
HANNOVER

ITALIA

EMILIA ROMAGNA
MELDOLA

Integrazione multiomica e caratterizzazione multilivello dei disordini e delle neoplasie maligne ematologiche
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

PORTOGALLO

NORTE
PORTO

Clinical implications of activation of PI3K/Akt signaling pathway in primary adult acute lymphoblastic leukemia.
Hospital de Santo António - Centro Hospitalar do Porto
Unidade de Imunologia Clínica

PORTOGALLO

SUL
LISBOA

SPAGNA

Cataluña
BADALONA

Treatment of BCR-ABL Negative ALL in Adults According to MRD and Genetics - ES
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Hematología Clínica

SPAGNA

País Vasco
BARAKALDO

New pharmacogenomic signature of treatment response prediction by studying non-coding RNAs in leukemia
Instituto de Investigación sanitaria Biocruces Bizkaia
Grupo de investigación en oncología pediátrica

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCBiomarkers of vincristine-induced peripheral neuropathy
Institution: Information not provided - US

SVEZIA

Region Skåne
LUND

Hematopoietic stem cell proliferation in development and in acute lymphoblastic leukemia
Lund University
Department of Experimental Medical Science

SVEZIA

Region Stockholm
STOCKHOLM

Transcriptional mechanisms by Notch and E2A proteins in lymphocyte development and ALL
Karolinska Institutet - Solna
The Institute of Environmental Medicine

SVIZZERA

Suisse Alémanique
ZÜRICH

Niche-based modeling and therapeutic targeting of highly resistant acute lymphoblastic leukemia
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

SVIZZERA

Suisse Romande
LAUSANNE

Deciphering the impact of chromosomal alterations on genome topology of lymphoma
EPFL - Ecole Polytechnique Fédérale de Lausanne
ISREC Institut Suisse de Recherche Expérimentale sur le Cancer - Elisa Oricchio Lab

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
WIEN

Finanziato da un ente associato a IRDiRCEuroTCLym - Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

AUSTRIA

WIEN
WIEN

Finanziato da un ente associato a IRDiRCERANET-PLL: Implementation of (epi)genetic and metabolic networks in the targeting of T-cell prolymphocytic leukemia - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

AUSTRIA

WIEN
WIEN

Identification of immune signatures underlying therapy with the bispecific T-cell engager Blinatumomab
Medizinische Universität Wien
Klinische Abteilung für Medizinische und Chemische Labordiagnostik

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Finanziato da un ente associato a IRDiRCEuroTCLym: Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets - FR
CHU de Clermont-Ferrand - Hôpital d'Estaing
Service de Thérapie cellulaire et Hématologie clinique

GERMANIA

Baden-Württemberg
ULM

PORTOGALLO

SUL
LISBOA

Do miRNAs and TAL1 crosstalk? New insights into the regulation and function of a major T-cell oncogene
Faculdade de Medicina da Universidade de Lisboa
Unidade de Biologia do Cancro

SPAGNA

Madrid
CANTOBLANCO

Novel immunotherapeutic strategies against T-ALL, a rare pediatric disease
CBMSO - Centro de Biología Molecular Severo Ochoa
Desarrollo del sistema linfohematopoyético humano

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCGenetic and biochemical approaches to tyrosine kinase function
Institution: Information not provided - US

AUSTRIA

WIEN
WIEN

Drug impact on cell-cell interactome in DLBCL (diffuse large B-cell lymphoma)
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

AUSTRIA

WIEN
WIEN

Christian Doppler Laboratory for Applied metabolomics
Medizinische Universität Wien
Klinische Abteilung für Nuklearmedizin

AUSTRIA

WIEN
WIEN

Christian Doppler Laboratory for Applied metabolomics
Medizinische Universität Wien
Klinisches Institut für Pathologie

FRANCIA

AUVERGNE-RHONE-ALPES
LYON

Finanziato da un ente associato a IRDiRCEstablish a model of follicular lymphoma in the chick embryo to personalize the treatment decision
CLCC Léon Bérard
Cancérologie médicale - Cancers hématologiques

FRANCIA

ILE-DE-FRANCE
CRÉTEIL

Positron Emission Tomography (PET)-Scan in the evaluation of high tumor burden follicular lymphoma
Hôpitaux Universitaires Henri Mondor
Service de médecine nucléaire

FRANCIA

OCCITANIE
TOULOUSE

Dialogue between Follicular Helper T-cells (TFH) and B-lymphocytes: Impact on the origin and heterogeneity of TFH in the context of Follicular Lymphoma
Centre de Physiopathologie de Toulouse Purpan
Cellules présentatrices de l'Antigène et Réponses T CD4

GERMANIA

Nordrhein-Westfalen
MÜNSTER

The role of MALT1 in the molecular pathogenesis of mantle cell lymphoma
Universitätsklinikum Münster
Medizinische Klinik und Poliklinik A

ITALIA

EMILIA ROMAGNA
MELDOLA

Indice Clinico Molecolare Misto (MMCI) nel linfoma diffuso a grandi cellule B (DLBCL)
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALIA

LIGURIA
GENOVA

SPAGNA

Castilla - León
SALAMANCA

SPAGNA

Cataluña
BARCELONA

SPAGNA

Madrid
MAJADAHONDA

Finanziato da un ente associato a IRDiRCFunctional genomics for precision medicine in aggressive B-cell lymphomas
Instituto de Investigación Sanitaria Puerta de Hierro
Fundación para la Investigación Biomédica del Hospital Puerta de Hierro

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCHts enabled examination of drug combinations
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRag and aid biology
Institution: Information not provided - US

SVEZIA

Region Stockholm
STOCKHOLM

SVIZZERA

Suisse Alémanique
ZÜRICH

The Swiss Pediatric Hematology/ Oncology Metabank - a network for precision medicine research
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

AUSTRIA

WIEN
WIEN

Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Finanziato da un ente associato a IRDiRCEuropean Reference Network on Paediatric Cancer Connecting Facility 2 - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Finanziato da un ente associato a IRDiRCERN-PAEDCAN Partner: Paediatric Rare Tumours Network - European Registry [PARTNER] - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

CANADA

Ontario
TORONTO

FRANCIA

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

GERMANIA

Baden-Württemberg
HEIDELBERG

Finanziato da un ente associato a IRDiRCERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

GERMANIA

Baden-Württemberg
HEIDELBERG

Multi-center registry study on proton radiotherapy for mediastinal lymphomas
Neurologische Universitätsklinik Heidelberg
Klinik für Radioonkologie und Strahlentherapie

STATI UNITI

South Dakota
SOUTH DAKOTA

Finanziato da un ente associato a IRDiRCImproving treatment for Epstein Barr Virus (EBV) induced cancer
Sanford Research/University of South Dakota
Cancer Biology Research Center

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

SVIZZERA

Suisse Italienne
BELLINZONA

Discovery of genetic/epigenetic addictions in NOTCH2/KLF2-mutated lymphoma
Istituto di Ricerca in Biomedicina
Istituto oncologico di ricerca (IOR)

AUSTRIA

WIEN
WIEN

A pilot study to compare mycosis fungoides and atopic eczema using single cell RNA sequencing
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Dermatologie

Progetti di ricerca multicentrici